MORGANTOWN — Pfizer and two of its subsidiaries have agreed to a $345 million settlement in a four-year class-action antitrust lawsuit concerning Mylan’s EpiPen. Pfizer subsidiary Meridian […]
Tag: EpiPen
Mylan scores several victories in federal antitrust lawsuit regarding EpiPen
MORGANTOWN – Mylan and its successor Viatris won a significant victory in a federal class-action antitrust suit alleging Mylan used its monopoly power to stifle competition and […]
Viatris/Mylan win EpiPen suit filed by competitor Sanofi
MORGANTOWN — Viatris announced Friday that its predecessor Mylan has won a lawsuit filed by competitor Sanofi that alleged Mylan employed anticompetitive tactics to snuff out Sanofi’s […]
